Model comparisons of competing Risk and recurrent events for graft failure in renal transplant recipients

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 2, 2013, Pages 241-247

  Holme, Ingar ^a   Fellström, Bengt C ^b   Jardine, Alan G ^c   Hartmann, Anders ^d   Holdaas, Hallvard ^d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FLUINDOSTATIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DR ANTIGEN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL (TOPIC); DEATH; FEMALE; FOLLOW UP; GRAFT FAILURE; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; RECURRENT DISEASE; RISK FACTOR; SMOKING; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, STATISTICAL; RECURRENCE; RISK ASSESSMENT;

EID: 84875035923     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03760412     Document Type: Article

References (17)

1. Cook RJ, Lawless JF: Marginal analysis of recurrent events and a terminating event. Stat Med 16: 911-924, 1997
2. Wei LJ, Glidden DV: An overview of statistical methods for multiple failure time data in clinical trials. Stat Med 16: 833-839, discussion 841-851, 1997
3. Metcalfe C, Thompson SG: Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: Should it be applied to a recurrent events outcome? Stat Methods Med Res 16: 103-122, 2007
4. Tikkanen MJ, Szarek M, Fayyad R, Holme I, Cater NB, Faergeman O, Kastelein JJP, Olsson AG, Larsen ML, Lindahl C, Pedersen TR; IDEAL Investigators;: Total cardiovascular disease burden: Comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial. J AmColl Cardiol 54: 2353-2357, 2009
5. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509, 1999
6. Shastri S, Tangri N, TighiouartH, Beck GJ, Vlagopoulos P, OrntD, Eknoyan G, Kusek JW, Herzog C, Cheung AK, Sarnak MJ: Predictors of sudden cardiac death: A competing risk approach in the hemodialysis study. Clin J AmSoc Nephrol 7: 123-130, 2012
7. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, Mä rzW, Abedini S, Norby GE, Holme I, FellströmB, Jardine A, Holdaas H: Inflammation-associated graft loss in renal transplant recipients. Nephrol Dial Transplant 26: 3756-3761, 2011
8. Wei LJ, Lin DY, Weissfeld L: Regression analysis of multivariate incomplete failure time data bymodellingmarginal distributions. J Am Stat Assoc 84: 1065-1073, 1989
9. Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR: Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 361: 2024-2031, 2003
10. Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators;: Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. Am J Transplant 5: 2929-2936, 2005
11. FellströmB, HoldaasH, Jardine AG, NybergG, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators;: Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial. Transplantation 79: 205-212, 2005
12. Lin DY, Wei LJ: The robust inference for the Cox proportional hazards model. J Am Stat Assoc 84: 1074-1078, 1989
13. Prentice RL, Williams BJ, Peterson AV:On the regression analysis of multivariate failure time data. Biometrika 68: 373-379, 1981
14. Gagnon DR, Zhang T-J, Brand FN, Kannel WB: Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J 127: 674-682, 1994
15. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: High blood hemoglobin concentration as a risk factor of major atherosclerotic events in 114,159 healthy men and women in the Apolipoprotein Mortality RISk study (AMORIS). Ann Med 44: 476-486
16. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346: 580-590, 2002
17. Schaeffner ES, Födinger M, Kramar R, Frei U, Hörl WH, Sunder-Plassmann G, Winkelmayer WC: Prognostic associations between lipid markers and outcomes in kidney transplant recipients. Am J Kidney Dis 47: 509-517, 2006